Novel Coronavirus halka açık
[search 0]
Daha fazla
Download the App!
show episodes
 
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We ...
  continue reading
 
Loading …
show series
 
The U.S. is experiencing another uptick in COVID infections after the holidays, with hospitalizations rising for the eighth week in a row. A new dominant variant, JN.1, has quickly spread to account for more than 60 percent of cases. John Yang speaks with epidemiologist Jessica Malaty Rivera to learn more about the surge and what it tells us about …
  continue reading
 
As we head into the winter holidays, John Yang speaks with epidemiologist Katelyn Jetelina about the current state of affairs with COVID, RSV and flu infections, lagging vaccination rates and how to stay healthy this season. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/fundersPBS NewsHour tarafından oluşturuldu
  continue reading
 
This week, the World Health Organization ended the global public health emergency it declared three years ago as COVID-19 spread around the world. Meanwhile, the U.S. public health emergency is set to end on Thursday, May 11. Katelyn Jetelina, an epidemiologist at the University of Texas, joins John Yang to discuss where the pandemic stands now and…
  continue reading
 
As students and teachers across the U.S. prepare to head back to school, the CDC is relaxing its COVID-19 guidelines. It marks a significant shift in how the nation approaches the pandemic as the new guidance prioritizes keeping kids in class. But some health experts worry the agency has gone too far. Julia Raifman, who leads the COVID-19 U.S. Stat…
  continue reading
 
More than two years into the pandemic, most Americans have returned to a sense of some normalcy. But the virus is still disrupting daily life in the U.S. with more than 130,000 per day and deaths on the rise. We reached out to viewers about their latest questions on COVID-19. Katelyn Jetelina, an epidemiologist with the University of Texas, joins J…
  continue reading
 
From the start of the pandemic, scientists have tried to determine exactly where and how the novel coronavirus spread to humans. New studies conclude the virus first emerged from a live-animal market in Wuhan, China. One of the authors of a study, Angela Rasmussen, a virologist at University of Saskatchewan's Vaccine and Infectious Disease Organiza…
  continue reading
 
A new coronavirus variant called BA.5 is fueling yet another wave of COVID infections across the globe. This week, the CDC said BA.5 is now the dominant strain in the U.S. accounting for more than 60 percent of cases. It is also the most transmissible variant to date. Dr. Eric Topol, founder and director of the Scripps Research Translational Instit…
  continue reading
 
With vaccinations, boosters and drugs, COVID has become a far less deadly risk for most Americans than earlier in the pandemic. But COVID still presents numerous problems, particularly for some of the most vulnerable people, with an average of more than 300 people dying every day from it. Dr. Ashish Jha, the White House COVID response coordinator, …
  continue reading
 
One of the major consequences of the coronavirus is that children around the world have been unable to attend schools to learn and are too poor to have computers and thus can't learn remotely. This is especially a problem in poor, less developed countries. We take a look at the issue with reports from three countries around the world in Venezuela, …
  continue reading
 
The pandemic threatened business districts across the country, but misguided fears and rhetoric about Asian Americans made things particularly hard for Chinatown neighborhoods. John Yang visited New York's Chinatown to learn more. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders…
  continue reading
 
China and Russia on Thursday blocked a U.S. attempt in the United Nations Security Council to punish North Korea for testing missiles that are banned by previous resolutions by the council. North Korea's tests this week of ballistic missiles, including one that Pyongyang says can reach the east coast of the U.S., coincide with its first major outbr…
  continue reading
 
A new COVID wave is accelerating across the U.S. with cases rising in almost every state. New daily cases are up by more than 50 percent from just two weeks ago, while COVID-related hospitalizations rose by 12 percent over the last week. This as the CDC signed off on Pfizer COVID boosters for children ages 5 to 11. White House COVID response direct…
  continue reading
 
President Biden on Thursday marked the U.S. nearing one million lives lost due to the pandemic and called on Congress to pass funding for more COVID relief. The pandemic has claimed more than 6 million lives worldwide, though WHO estimates the real toll tops 15 million deaths tied to the virus. Dr. Anthony Fauci, Biden's chief medical adviser, join…
  continue reading
 
It's a tiny vial with big ambitions to help bring an end to the pandemic everywhere on earth. The developers of the so-called "vaccine for the world" hope what's inside can ease the equity issues surrounding global covid vaccine distribution. John Yang has the story. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders…
  continue reading
 
As COVID cases begin to pick up across the U.S. the Centers for Disease Control and Prevention on Tuesday said that three out of every four children have been infected by COVID. This comes as the White House moved to make Paxlovid pills, which can reduce serious illness, more widely available. Dr. Anthony Fauci, President Biden's chief medical advi…
  continue reading
 
With the rise of the BA.2 variant in some parts of the country, many questions remain about how to best navigate daily life and what precautions should or should not be taken. White House COVID-19 response coordinator Dr. Ashish Jha joins Amna Nawaz to discuss. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/funders…
  continue reading
 
Shanghai is under lockdown Friday, as COVID cases continue to surge in China's financial capital. It is the most severe measure by the Chinese government to isolate and tract infections since it shut down the city of Wuhan after the virus broke out in 2020. William Brangham reports. PBS NewsHour is supported by - https://www.pbs.org/newshour/about/…
  continue reading
 
As COVID-19 swept across the United States it became clear that the virus disproportionately affected certain racial and ethnic groups. But the outsized impact of the pandemic on one community -- Native Hawaiians and Pacific Islanders -- has been largely hidden because of inconsistent data collection and reporting. Stephanie Sy reports as part of o…
  continue reading
 
Two years into the pandemic, concerns about COVID-19's impact on mental health continue to grow. We spoke to people across the country about their particular struggles and the work being done to help others suffering during the pandemic. And Dr. Tom Insel, who served as the director of the National Institute of Mental Health, joins Judy Woodruff to…
  continue reading
 
The World Health Organization reported infections are down globally. In the last two weeks, new cases in the U.S. have decreased by more than 60 percent and a number of states and cities have been lifting masking requirements. But experts warn about letting our guard down too soon. Dr. Anthony Fauci, chief medical adviser to President Biden, joins …
  continue reading
 
With the holidays approaching and the omicron variant surging in some parts of the U.S., demand for rapid and at-home COVID-19 tests is higher than ever, and the wait at large PCR test sites can be several hours in some places. ProPublica reporter Lydia Depillis joins Hari Sreenivasan to discuss why the tests are so hard to find in the U.S., and th…
  continue reading
 
A newly emerged variant of the coronavirus known as "omicron" is causing widespread concern. First discovered in South Africa, it's now been detected in multiple nations, including Europe and Israel. Many nations including the U.S. are considering travel bans to try and contain the variant. Dr. Ashish Jha, dean of Brown University's School of Publi…
  continue reading
 
New York Times columnist David Brooks and Washington Post columnist Jonathan Capehart join William Brangham to discuss the week in politics, including the new COVID- 19 variant, inflation, President Biden's leadership decisions at the Federal Reserve and the verdict in the death of Ahmaud Arbery. PBS NewsHour is supported by - https://www.pbs.org/n…
  continue reading
 
COVID-19 was the number one cause of death for people between the ages of 35 to 54 during some months since the pandemic began last year, according to recent data. Meanwhile, as the Delta variant continues to drive infections around the world, the push for booster shots in the U.S. has raised concerns since many are still awaiting their first dose.…
  continue reading
 
The CDC wants to be certain, so it typically waits for a critical mass of scientific evidence before making declarative statements. That takes time. Yet the communication to the public in this pandemic seemed to be worse than normal, and resulted in a huge loss of public trust. Over the past month, we spoke to nearly a dozen scientists who all agre…
  continue reading
 
We have no hard evidence to support the idea that the novel coronavirus was leaked from a lab, let alone a smoking gun to validate that hypothesis. But despite pushback on this story from many scientists and the media early on, it’s back in the news, and many are talking about the possibility of a lab leak. There may be some legitimate reasons to d…
  continue reading
 
Community colleges have long been seen as an opportunity for students of all backgrounds to earn a degree. But those same students, especially the students of color, have been some of the hardest hit by the COVID-19 pandemic. And many have had to drop out. But schools are hoping to bring students back with new initiatives. Hari Sreenivasan reports …
  continue reading
 
There's a worldwide shortage of vaccines but plenty of factories standing by to make them. Why is there such a gap between what we need and what we can make? On this week's episode, we explore the surprisingly wild world of pharmaceutical patent law to understand how our system came to be and how it has shaped the pandemic.…
  continue reading
 
Kids can't get a COVID-19 vaccination yet, but they're unlikely to develop serious complications from the disease. But they can still be vectors to spread COVID-19 to others who are likely to get very sick. On this week's episode, we look into how big of a risk unvaccinated kids pose to society, and what parents should keep in mind.…
  continue reading
 
We've learned time and again that animals can give diseases to humans. We've seen this happen with coronaviruses, the flu, Ebola -- basically most major disease outbreaks in recent memory. But, of course, the reverse is true too: Humans can give viruses, including the novel coronavirus, to animals. FiveThirtyEight’s senior science writer Maggie Koe…
  continue reading
 
The United States has a surplus of COVID-19 vaccines — more than enough to vaccinate every adult. Poor countries, however, are still struggling to secure doses. Should those vaccines be sent to countries in need? If not, who will do the sending? And should rich countries profit off the exchange?FiveThirtyEight, Anna Rothschild tarafından oluşturuldu
  continue reading
 
Federal health agencies asked states to pause in their use of the Johnson & Johnson vaccine while U.S. officials investigate reports of an extremely rare blood-clotting syndrome that has developed in six people who have received the vaccine. Given how few people are sick, why did the U.S. recommend a pause? And what's it say about how the monitorin…
  continue reading
 
The AstraZeneca COVID-19 vaccine has been hailed as the world’s vaccine -- it’s inexpensive to produce and doesn’t need super-cold storage like the mRNA vaccines do. But its rollout has been messy. Will its missteps erode the public's (or the FDA's) trust? Maggie Koerth joins to discuss.FiveThirtyEight, Anna Rothschild tarafından oluşturuldu
  continue reading
 
At some point, the U.S. is going to run out of people eager to get the vaccine, and we’ll need to work hard to convert those who are still hesitant or don’t know how to get it. It won’t be the first time we’ve done so. For months, community leaders have been working to overcome transportation challenges, language barriers, and digital divides. We s…
  continue reading
 
Anna talks with Dr. Margaret Liu, one of the pioneers of gene-based vaccines, about vaccines that use mRNA to help us build immunity to COVID-19, including the Pfizer-BioNTech and Moderna vaccines. How is this method different from vaccines in the past, and what does the mRNA do once it gets inside our bodies?…
  continue reading
 
Data has been such a valuable commodity during the pandemic. Unfortunately, at times data has been in short supply, because US government agencies haven’t always undertaken national data collection efforts. So what happens when individuals citizens try to collect data themselves? We talk to Professor Emily Oster, who developed a national COVID-19 S…
  continue reading
 
It feels like a cure for this pandemic may be in sight. But for many people, injecting a brand-new scientific discovery into their body won't sit well. So, how are scientists making sure that a COVID-19 vaccine won’t cause more damage than the disease? How do regulators decide what an acceptable side effect is? And what would happen if someone did …
  continue reading
 
After testing positive for COVID-19 last week, President Trump was given the three experimental drugs: an antiviral, monoclonal antibodies, and a steroid. On this week’s episode of PODCAST-19, we discuss what happens when all three drugs are combined and why the average American can't expect to receive the same treatment.…
  continue reading
 
Today we learned that President Trump tested positive for COVID-19. In this special crossover episode, the crew from the FiveThirtyEight Politics podcast sat down with senior science writer and Podcast-19 contributor Maggie Koerth to talk about medical implications for the President, and the impact his diagnosis might have on the election.…
  continue reading
 
As schools of all levels struggle to find a new way to educate students, universities, in particular, have had a difficult time navigating classes and campus life. On this week's show, we talk to a student navigating quarantined dorm life at the University of Wisconsin-Madison and a scientist who helped design a different approach to testing for th…
  continue reading
 
Loading …

Hızlı referans rehberi